CORC  > 中国医学科学院 北京协和医学院
Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling
Lyu Yuelei; Liu Shuai; You Hui; Hou Bo; Wang Yu; Ma Wenbin; Feng Feng
2017
卷号46期号:2页码:565-573
关键词arterial spin labeling recurrent high-grade gliomas bevacizumab cerebral blood flow overall survival progression-free survival
ISSN号1053-1807
DOI10.1002/jmri.25558
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6367392
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Lyu Yuelei,Liu Shuai,You Hui,et al. Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling[J],2017,46(2):565-573.
APA Lyu Yuelei.,Liu Shuai.,You Hui.,Hou Bo.,Wang Yu.,...&Feng Feng.(2017).Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling.,46(2),565-573.
MLA Lyu Yuelei,et al."Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling".46.2(2017):565-573.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace